RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer
NCT03000764 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-08-08
Summary
The purpose of this study is to seeking a molecular signature of pathological radiation induced fibrosis based on the response of skin fibroblasts after irradiation, comparing two groups of patients distinguished by their individual radiosensitivity. The signature will integrate recent insights in terms of alternative splicing of mRNAs and level of expression of non-coding RNAs, particularly long non-coding RNAs, snRNAs, snoRNAs and microRNAs. In each group each expression patterns of candidate HSP proteins potentially predictive of pathological radiation induced fibrosis (HSP27, HSP70, αβ crystalline) in the serum and on cell culture will be characterized.
Conditions
- Breast Carcinoma
- Fibrosis
Interventions
- OTHER
-
skin biopsies
Biopsies (12 G) will be performed : * in non-irradiated breast skin * in irradiated breast skin
- OTHER
-
blood samples
blood samples are collected: * 10 ml in EDTA tube * 2,5 ml in PAXgene Blood RNA tube * 4 ml in EDTA tube
Sponsors & Collaborators
-
Institut de Cancérologie de Lorraine
lead OTHER
Principal Investigators
-
VOGIN GUILLAUME, MD, PhD · Institut de Cancérologie de Lorraine
-
BEHM-ANSMANT Isabelle, PhD · UMR 7365 CNRS-Université de Lorraine, IMoPA
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-10
- Primary Completion
- 2018-04-18
- Completion
- 2018-04-25
Countries
- France
Study Locations
More Related Trials
-
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
NCT05054010 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
NCT02761616 ·Status: COMPLETED
-
Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer
NCT01008514 ·Status: WITHDRAWN ·Phase: PHASE2
-
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
NCT07276880 ·Status: RECRUITING ·Phase: PHASE2
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
NCT01247480 ·Status: UNKNOWN
-
Molecular Signature for Breast Cancer
NCT05724407 ·Status: UNKNOWN
-
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
NCT04273542 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
NCT01316328 ·Status: COMPLETED
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT05817227 ·Status: RECRUITING
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
NCT01232881 ·Status: TERMINATED
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy
NCT00581529 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
NCT06382818 ·Status: RECRUITING ·Phase: NA
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING
-
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
NCT03801850 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.
NCT05318274 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intraoperative Radiotherapy for Early Stage Breast Cancer
NCT01189851 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Breast Tumor Microenvironment
NCT03165487 ·Status: ACTIVE_NOT_RECRUITING